4-(5-pyridin-4-yl-1H-(1,2,4) triazol-3-yl)pyridine-2-carbonitrile,
FYX-051,
topiroxostat,
Topiroxostat,
577778-58-6,
FYX 051,
FYX-051,
4-(5-PYRIDIN-4-YL-1H-1,2,4-TRIAZOL-3-YL)PYRIDINE-2-CARBONITRILE,
UNII-0J877412JV,
CHEMBL1078685,
2-Pyridinecarbonitrile, 4-[5-(4-pyridinyl)-1H-1,2,4-triazol-3-yl]-,
0J877412JV,
5-(2-cyano-4-pyridyl)-3-(4-pyridyl)-1,2,4-triazole,
AK310366,
4-(5-(Pyridin-4-yl)-1h-1,2,4-triazol-3-yl)pyridine-2-carbonitrile,
4-[5-(pyridin-4-yl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile,
4-[5-PYRIDIN-4-YL-1H-[1,2,4]TRIAZOL-3-YL]-PYRIDINE-2-CARBONITRILE,
Topiroxostat [INN],
Uriadec (TN),
Topiroxostat/FYX 051,
AC1NRB9T,
Topiroxostat (JAN/INN),
SCHEMBL860420,
SCHEMBL18056618,
CTK1F1296,
DTXSID80206462,
UBVZQGOVTLIHLH-UHFFFAOYSA-N,
BCP09957,
EX-A1197,
(FYX-051),
BDBM50311275,
MFCD17167057,
ZINC13536586,
AKOS026750465,
AKOS026751485,
CS-2033,
DB01685,
NCGC00378610-01,
BC600687,
HY-14874,
SC-91234,
SY116097,
FT-0700966,
KS-00000215,
MFCD17167057 (95%),
A14144,
D09786,
4-(3-(Pyridin-4-yl)-1H-1,2,4-triazol-5-yl)picolinonitrile,
4-(5-(pyridin-4-yl)-1H-1,2,4-triazol-3-yl)picolinonitrile,
4-[5-(4-Pyridyl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile,
topiloric,
uriadec,
D0WK0P,
ACN-048289,
CID5288320,
SK-0910,
B1192,
C504882,
Xanthine oxidoreductase inhibitor (oral, gout), Fuji Yakuhin,
4-(5-pyridin-4-yl-1H-(1,2,4) triazol-3-yl)pyridine-2-carbonitrile,
4-[3-(4-pyridinyl)-1H-1,2,4-triazol-5-yl]-2-Pyridinecarbonitrile,
FYX,